Quince Therapeutics, Inc. (QNCX) M&A Call Prepared Remarks Transcript
· seekingalpha.com
Quince Therapeutics, Inc. (QNCX) M&A Call May 18, 2026 10:00 AM EDTCompany ParticipantsDirk Thye - CEO, Chief Medical Officer & DirectorBrigette...
Presentation
Good morning, and welcome to the acquisition of OrphAI Therapeutics by Quince Therapeutics Webcast and Conference Call. [Operator Instructions] Pl...